Cargando…
Targeting HMGB1: An available Therapeutic Strategy for Breast Cancer Therapy
HMGB1 is a member of highly conserved high mobility group protein superfamily with intracellular and extracellular distribution. Abnormal HMGB1 levels are frequently manifested in various malignant diseases, including breast cancer. Numerous studies have revealed the clinical value of HMGB1 in the d...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Ivyspring International Publisher
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134916/ https://www.ncbi.nlm.nih.gov/pubmed/35637945 http://dx.doi.org/10.7150/ijbs.73504 |